Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
Titel:
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
Auteur:
Straatmijer, Tessa Biemans, Vince B.C. Visschedijk, Marijn Hoentjen, Frank de Vries, Annemarie van Bodegraven, Adriaan A. Bodelier, Alexander de Boer, Nanne K.H. Dijkstra, Gerard Festen, Noortje Horjus, Carmen Jansen, Jeroen M. Jharap, Bindia Mares, Wout van Schaik, Fiona D.M. Ponsioen, Cyriel Romkens, Tessa Srivastava, Nidhi van der Voorn, Michael M.P. J.A. West, Rachel van der Woude, Janneke Wolvers, Marije D.J. Pierik, Marieke van der Meulen-de Jong, Andrea E. Duijvestein, Marjolijn